184 related articles for article (PubMed ID: 38560405)
1. Is the Capsaicin 179 mg (8% w/w) Cutaneous Patch an Appropriate Treatment Option for Older Patients with Peripheral Neuropathic Pain?
Pickering G; Engelen S; Stupar M; Ganry H; Eerdekens M
J Pain Res; 2024; 17():1327-1344. PubMed ID: 38560405
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
[TBL] [Abstract][Full Text] [Related]
3. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Derry S; Rice AS; Cole P; Tan T; Moore RA
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD007393. PubMed ID: 28085183
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety profile of capsaicin 8% patch versus 5% Lidocaine patch in patients with diabetic peripheral neuropathic pain: a randomized, placebo-controlled study of south Asian male patients.
Hussain N; Said ASA; Javaid FA; Al Haddad AHI; Anwar M; Khan Z; Abu-Mellal A
J Diabetes Metab Disord; 2021 Jun; 20(1):271-278. PubMed ID: 34178837
[TBL] [Abstract][Full Text] [Related]
5. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Derry S; Sven-Rice A; Cole P; Tan T; Moore RA
Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576
[TBL] [Abstract][Full Text] [Related]
6. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J;
Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
[TBL] [Abstract][Full Text] [Related]
7. Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain.
Haanpää M; Cruccu G; Nurmikko TJ; McBride WT; Docu Axelarad A; Bosilkov A; Chambers C; Ernault E; Abdulahad AK
Eur J Pain; 2016 Feb; 20(2):316-28. PubMed ID: 26581442
[TBL] [Abstract][Full Text] [Related]
8. Capsaicin dermal patch: in non-diabetic peripheral neuropathic pain.
McCormack PL
Drugs; 2010 Oct; 70(14):1831-42. PubMed ID: 20836576
[TBL] [Abstract][Full Text] [Related]
9. Treatment Impact on Patient-Reported Outcomes in Peripheral Neuropathic Pain: Comparing Single Intervention With Topical High-Concentration Capsaicin to Daily Oral Pregabalin.
Viel E; Eerdekens M; Kandaswamy P
Pain Physician; 2021 Sep; 24(6):453-463. PubMed ID: 34554688
[TBL] [Abstract][Full Text] [Related]
10. Treatment of painful radiculopathies with capsaicin 8% cutaneous patch.
Baron R; Treede RD; Birklein F; Cegla T; Freynhagen R; Heskamp ML; Kern KU; Maier C; Rolke R; Seddigh S; Sommer C; Ständer S; Maihöfner C
Curr Med Res Opin; 2017 Aug; 33(8):1401-1411. PubMed ID: 28436279
[TBL] [Abstract][Full Text] [Related]
11. NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia.
Irving G; Backonja M; Rauck R; Webster LR; Tobias JK; Vanhove GF
Clin J Pain; 2012 Feb; 28(2):101-7. PubMed ID: 21753727
[TBL] [Abstract][Full Text] [Related]
12. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study.
Maihofner C; Heskamp ML
Curr Med Res Opin; 2013 Jun; 29(6):673-83. PubMed ID: 23551064
[TBL] [Abstract][Full Text] [Related]
13. The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis.
Wagner T; Poole C; Roth-Daniek A
Pain Med; 2013 Aug; 14(8):1202-11. PubMed ID: 23710678
[TBL] [Abstract][Full Text] [Related]
14. Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: a multicentre, randomized, assessor-blinded study.
Jensen TS; Høye K; Fricová J; Vanelderen P; Ernault E; Siciliano T; Marques S
Eur J Pain; 2014 Oct; 18(9):1240-7. PubMed ID: 24664539
[TBL] [Abstract][Full Text] [Related]
15. 8% Capsaicin Patch in Treatment of Peripheral Neuropathic Pain.
Goncalves D; Rebelo V; Barbosa P; Gomes A
Pain Physician; 2020 Sep; 23(5):E541-E548. PubMed ID: 32967405
[TBL] [Abstract][Full Text] [Related]
16. Progressive Response to Repeat Application of Capsaicin 179 mg (8% w/w) Cutaneous Patch in Peripheral Neuropathic Pain: Comprehensive New Analysis and Clinical Implications.
Freynhagen R; Argoff C; Eerdekens M; Engelen S; Perrot S
Pain Med; 2021 Oct; 22(10):2324-2336. PubMed ID: 33871648
[TBL] [Abstract][Full Text] [Related]
17. Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice.
Hansson P; Jensen TS; Kvarstein G; Strömberg M
Eur J Pain; 2018 May; 22(5):941-950. PubMed ID: 29388284
[TBL] [Abstract][Full Text] [Related]
18. Efficacy Analysis of Capsaicin 8% Patch in Neuropathic Peripheral Pain Treatment.
Tenreiro Pinto J; Pereira FC; Loureiro MC; Gama R; Fernandes HL
Pharmacology; 2018; 101(5-6):290-297. PubMed ID: 29587275
[TBL] [Abstract][Full Text] [Related]
19. Capsaicin 8% Patch Repeat Treatment in Nondiabetic Peripheral Neuropathic Pain: A 52-Week, Open-Label, Single-Arm, Safety Study.
Gálvez R; Navez ML; Moyle G; Maihöfner C; Stoker M; Ernault E; Nurmikko TJ; Attal N
Clin J Pain; 2017 Oct; 33(10):921-931. PubMed ID: 28872473
[TBL] [Abstract][Full Text] [Related]
20. Capsaicin 179-mg cutaneous patch in the treatment of post-surgical neuropathic pain: a scoping review of current evidence and place in therapy.
Casale R
Expert Rev Neurother; 2021 Oct; 21(10):1147-1158. PubMed ID: 34461799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
